MedPath

Optimum Misoprostol Dose Prior to Office Hysteroscopy

Phase 3
Completed
Conditions
Infertility
Abnormal Uterine and Vaginal Bleeding, Unspecified
Recurrent Abortion
Interventions
Registration Number
NCT01612065
Lead Sponsor
Cairo University
Brief Summary

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.

Detailed Description

The investigators will compare between 2 different doses of vaginal misoprostol, group (1) 200 ug, group (2) 400 ug, 3hours prior to office hysteroscopy , Infertile patient, patients with abnormal bleeding and patient with recurrent abortion Outcome measure: pain score, easiness of the procedure, procedure time, complications

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
132
Inclusion Criteria
  • Female patient pre- or postmenopausal undergo office hysteroscopy.
  • Age: from 20 to 60.
  • BMI between 18 and 30.
Exclusion Criteria
  • PID or
  • Heavy uterine bleeding
  • Cervical malignancy.
  • Symptoms suggestive of endometriosis .
  • Any cervical abnormality such as pinhole cervix that would obviate passage of a catheter through the cervix.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Misoprostol vaginally, 200 ugMisoprostol200 ug misoprostol in the posterior vaginal fornix
Misoprostol vaginally, 400ugMisoprostolMisoprostol in the posterior vaginal fornix
Primary Outcome Measures
NameTimeMethod
Pain score1year

Pain score by VAS

Secondary Outcome Measures
NameTimeMethod
Easiness1year

ease of entry of the office hysteroscopy into the cervix recorded on a 5-point Likert scale: very difficult= 1, difficult = 2, fair = 3, easy = 4, and very easy = 5;

Duration of the procedure1year

Duration of hysteroscopy in seconds

Trial Locations

Locations (1)

Kasr alainy hospital, faculty of medicine , Cairo university

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath